These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The definition of refractoriness to platelet transfusions. Bishop JF; Matthews JP; Yuen K; McGrath K; Wolf MM; Szer J Transfus Med; 1992 Mar; 2(1):35-41. PubMed ID: 1308461 [TBL] [Abstract][Full Text] [Related]
4. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets. Levy L; Woodfield DG N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558 [TBL] [Abstract][Full Text] [Related]
15. Complement as an Immune Barrier in Platelet Transfusion Refractoriness. Meinke S; Karlström C; Höglund P Transfus Med Rev; 2019 Oct; 33(4):231-235. PubMed ID: 31679761 [TBL] [Abstract][Full Text] [Related]
16. [Transfusion of platelet concentrates]. Rieux C; Lee K; Lavaud A; Bierling P Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645 [TBL] [Abstract][Full Text] [Related]
17. The clot: platelet transfusion. Chapman R Rocky Mt Med J; 1977; 74(3):146-50. PubMed ID: 301288 [No Abstract] [Full Text] [Related]
18. Blood component therapy in the treatment of platelet disorders. Eisenstaedt R Semin Hematol; 1986 Jan; 23(1):1-7. PubMed ID: 3511534 [No Abstract] [Full Text] [Related]
19. Thrombocytopenia in the newborn. Gill FM Semin Perinatol; 1983 Jul; 7(3):201-12. PubMed ID: 6359431 [TBL] [Abstract][Full Text] [Related]
20. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia? Benjamin RJ; Anderson KC Crit Rev Oncol Hematol; 2002 May; 42(2):163-71. PubMed ID: 12007974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]